USA researchers identify potential biomarkers for detection and treatment of triple-negative breast cancer

$ 27.00

4.7
(554)
In stock
Description

“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”

Frontiers Potential Predictive and Prognostic Value of

Proteogenomics reveals markers of chemotherapy resistance and

Breast Cancer Research Foundation of Alabama (@bcrfalabama) • Instagram photos and videos

Relevant breast cancer biomarkers at different time points in

Advances in BRCA-associated and triple-negative breast cancer

Seema Singh, Ph.D.

Breast Cancer Research Foundation of Alabama on LinkedIn: This tag funds research in Tuskegee! When you get the Breast Cancer…

Life, Free Full-Text

7 Recommendations for Future Research